3-D structure modeling of DRD2 wild type and mutant S311C.
Docking studies of DRD2 (WT and mutant) with natural agonist Dopamine.
Molecular dynamics (MD) simulations of modeled structures and docked complexes.
Protein–protein docking of dopamine bound DRD2 (WT and mutant) with Gαi/o and NEB2.